
### [NCIT:C7080](http://purl.obolibrary.org/obo/NCIT_C7080)
**Label:** Metastatic Malignant Neoplasm in the Prostate Gland

**Subclasses:** [NCIT:C39899](http://purl.obolibrary.org/obo/NCIT_C39899) (Secondary Prostate Urothelial Carcinoma), 

**Class expressions from DL-Learner:**

- [UBERON:0002367](http://purl.obolibrary.org/obo/UBERON_0002367) (prostate gland) 62.50%
- [NCIT:C41444](http://purl.obolibrary.org/obo/NCIT_C41444) (Secondary Lesion) 62.50%
- [NCIT:C40557](http://purl.obolibrary.org/obo/NCIT_C40557) (Metastatic Lesion) 62.50%
- [UBERON:0004119](http://purl.obolibrary.org/obo/UBERON_0004119) (endoderm-derived structure) and [UBERON:0010147](http://purl.obolibrary.org/obo/UBERON_0010147) (male accessory sex gland) 62.50%
- [UBERON:0000077](http://purl.obolibrary.org/obo/UBERON_0000077) (mixed endoderm/mesoderm-derived structure) and [UBERON:0010147](http://purl.obolibrary.org/obo/UBERON_0010147) (male accessory sex gland) 62.50%
- Thing 51.60%
- [UBERON:0010147](http://purl.obolibrary.org/obo/UBERON_0010147) (male accessory sex gland) 47.86%
- [UBERON:0004120](http://purl.obolibrary.org/obo/UBERON_0004120) (mesoderm-derived structure) and [UBERON:0010147](http://purl.obolibrary.org/obo/UBERON_0010147) (male accessory sex gland) 47.86%
- [UBERON:0010147](http://purl.obolibrary.org/obo/UBERON_0010147) (male accessory sex gland) and (not ([NCIT:C39016](http://purl.obolibrary.org/obo/NCIT_C39016) (EGF Receptor Downregulation by CBL Pathway))) 47.86%
- [UBERON:0010147](http://purl.obolibrary.org/obo/UBERON_0010147) (male accessory sex gland) and (not ([NCIT:C39013](http://purl.obolibrary.org/obo/NCIT_C39013) (Estrogen Receptor Regulation by CARM1 Pathway))) 47.86%
- [UBERON:0010147](http://purl.obolibrary.org/obo/UBERON_0010147) (male accessory sex gland) and (not ([NCIT:C39011](http://purl.obolibrary.org/obo/NCIT_C39011) (Cardiac Hypertrophy Pathway))) 47.86%
- [UBERON:0010147](http://purl.obolibrary.org/obo/UBERON_0010147) (male accessory sex gland) and (not ([NCIT:C3901](http://purl.obolibrary.org/obo/NCIT_C3901) (Compound Nevus))) 47.86%
- [UBERON:0010147](http://purl.obolibrary.org/obo/UBERON_0010147) (male accessory sex gland) and (not ([NCIT:C39006](http://purl.obolibrary.org/obo/NCIT_C39006) (Bioactive Peptide Signaling Pathway))) 47.86%
- [UBERON:0010147](http://purl.obolibrary.org/obo/UBERON_0010147) (male accessory sex gland) and (not ([NCIT:C39004](http://purl.obolibrary.org/obo/NCIT_C39004) (B-Cell Survival Pathway))) 47.86%
- [UBERON:0010147](http://purl.obolibrary.org/obo/UBERON_0010147) (male accessory sex gland) and (not ([NCIT:C38999](http://purl.obolibrary.org/obo/NCIT_C38999) (BARD1 Pathway))) 47.86%


